Title:
ENTEROVIRUS INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2020/216349
Kind Code:
A1
Abstract:
The present application falls within the field of medical technology, and in particular relates to the use of 9-[3-(6-amino)-pyridyl]-1-[(3-trifluoromethyl)-phenyl]benzo[h][1,6]naphthyridine-2(1H)-one (formula I), and a pharmaceutically acceptable salt thereof, a stereisomer thereof, or a hydrate or a solvate thereof, and a pharmaceutical composition containing the compound, which composition is used for resisting a wide spectrum of viruses, and especially relates to the use thereof for treating enterovirus infections.
More Like This:
| JPWO2006057270 | Nitrogen-containing tricyclic compound |
| WO/2014/089904 | TRIAZINONE COMPOUNDS |
| WO/2021/127466 | COMBINATION TREATMENT OF LIVER DISEASES USING INTEGRIN INHIBITORS |
Inventors:
ZHONG WU (CN)
CAO RUIYUAN (CN)
CHENG TONG (CN)
XIA NINGSHAO (CN)
LI SONG (CN)
CAO RUIYUAN (CN)
CHENG TONG (CN)
XIA NINGSHAO (CN)
LI SONG (CN)
Application Number:
PCT/CN2020/086835
Publication Date:
October 29, 2020
Filing Date:
April 24, 2020
Export Citation:
Assignee:
ACAD OF MILITARY MEDICAL SCIENCES (CN)
International Classes:
A61K31/4375; A61K31/438; A61K31/44; A61P1/02; A61P31/12; A61P31/16; A61P31/22; C07D471/04
Domestic Patent References:
| WO2018017426A1 | 2018-01-25 |
Foreign References:
| US20160339030A1 | 2016-11-24 | |||
| CN201910346258A | 2019-04-26 |
Other References:
See also references of EP 3960173A4
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF:
Previous Patent: BISPECIFIC ANTIBODIES AGAINST PD-1 AND LAG-3
Next Patent: QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
Next Patent: QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF